Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Prostate cancer risk linked to high cholesterol

Italian Researchers say they have found what they believe to be the first direct link between high cholesterol levels and prostate cancer.

12 Apr 2006

Review examines the management of radiotherapy induced rectourethal fistula

Rectourethral fistulas (RUF) are a challenging problem observed by urological and colorectal surgeons.

11 Apr 2006

Usage and outcomes of primary androgen deprivation therapy for localized prostate cancer

In the online March 2006 version of Cancer, Dr. Kawakami and associates report from the CaPSURE database that primary androgen deprivation therapy (PADT) is used in 14% of prostate cancer (CaP) patients with reasonable outcomes at approximately 5 years follow-up.

11 Apr 2006

Discovery of virus implicated in genetics of prostate cancer

The Open Access journal PLoS Pathogens has published an article detailing research that identifies a new retrovirus in the tissue of human prostate tumors.

10 Apr 2006

Discovery of new human retrovirus

Howard Hughes Medical Institute researchers and their colleagues have discovered a new retrovirus in humans that is closely related to a cancer-causing virus found in mice. Their findings describe the first documented cases of human infection with a retrovirus that is native to rodents.

10 Apr 2006

More than a billion may suffer from vitamin D deficiency

More than a billion may suffer from vitamin D deficiency. Consequences may be more severe than thought. Prominent clinician calls for action.

6 Apr 2006

Newly discovered testosterone effect may act on prostate cancer

A newly-discovered mode of action of testosterone is showing great promise in the fight against prostate cancer, with tests showing a 60% reduction in tumor size in mice.

6 Apr 2006

Inflammation cuts both ways

Inflammation cuts both ways. When invaded by an infectious agent, for example, the body calls on the forces of inflammation to fight and defeat the intruder.

6 Apr 2006

Vegetables slow growth of prostate cancer in mice

Chemicals in cruciferous vegetables, such as broccoli, watercress, cabbage and cauliflower, appear to stop human prostate cancer cells from growing in mice by affecting the expression of proteins, says a University of Pittsburgh Cancer Institute study

6 Apr 2006

Ingredient in red peppers inhibits prostate cancer in laboratory studies

Capsaicin is the pungent ingredient in red peppers and is presently used as a topical pain reliever. Now, a new study shows it may be justified to evaluate capsaicin for inhibiting prostate cancer (CaP) in patients.

5 Apr 2006

Researchers narrow search for effective prostate cancer biomarkers

Researchers at Mayo Clinic have narrowed the search for effective prostate cancer biomarkers (genetic variations that point to a specific disease or condition), identifying changes in the expression of genes of the whole genome closely correlated to prostate cancer development and progression.

4 Apr 2006

Why do men choose one prostate cancer treatment over another?

Men with prostate cancer generally make treatment decisions based on differences in the information they receive rather than their own preferences, according to a new review.

4 Apr 2006

Why do men choose one prostate treatment over another?

Men with prostate cancer generally make treatment decisions based on differences in the information they receive rather than their own preferences, according to a new review.

27 Mar 2006

Salvage radiation therapy for PSA recurrence following radical prostatectomy

Salvage radiation therapy to the prostatic fossa is often employed in patients with rising PSA after radical prostatectomy (RP). Interestingly, only 25% of men with rising PSA after RP have a positive prostatic fossa biopsy, yet 70% of men with a negative biopsy will have their PSA decline to undetectable levels following salvage external beam radiotherapy.

23 Mar 2006

Raloxifene shows potential benefits in treating prostate cancer

In a study to be published in the April, 2006 issue of the British Journal of Urology International, researchers at Cedars-Sinai Medical Center have shown that Raloxifene, a drug commonly used to treat osteoporosis, has a potential clinical benefit in treating men with prostate cancer.

23 Mar 2006